Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO -- Ignore unavailable to you. Want to Upgrade?

To: johnsto1 who wrote (20)	4/10/2000 11:32:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 368

Huh? I opened the level II on LYNX and it looks pretty dead right now. SNP scoring eh, lots of nifty biotechs out there. I did buy some SGMO...however, looks like I'm already down a few bucks for my trouble. It's a tough sector to keep hot-- a lot of cynical people who don't know any better can pretty much trash the sector and sound believable to the newbies. This was a great one--Kernan on CNBC has reminded us that Celera has only sequenced one person's genes--and apparently we all have different genes. Thanks Joe! Oh man, so lame. Semiconductors and B2B internuts are where all the money is going apparently. That's because many people have bought those two dollar compressed air cans and now know what a semiconductor looks like. And we all know that B2B is going to replace porno as the number one use of the net in the next few years--so you really cant start enough billion dollar B2B's can you? ROFL